-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $105

Benzinga·07/24/2026 17:46:06
Listen to the news
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $105.